New drug combo aims to outsmart recurrent ovarian cancer
NCT ID NCT05554328
First seen Jun 27, 2026 · Last updated Aug 05, 2026 · Updated 22 times
Summary
This phase 2 trial tests whether adding olaparib to selumetinib works better than selumetinib alone for women with recurrent or persistent ovarian or endometrial cancers that have a RAS pathway mutation. Selumetinib blocks enzymes that help cancer grow, while olaparib stops cancer cells from repairing their DNA. The study will enroll 165 participants and measure how long the cancer stays under control.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Selumetinib and olaparib
- What this could lead to
- If it works, this combination could offer a new targeted treatment option that shrinks tumors or keeps them stable longer in women with these hard-to-treat cancers.
- What could go wrong
- This is a mid-stage trial with only 165 participants, so results may not apply to everyone. Adding olaparib could also increase side effects without improving outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2
Tests whether the treatment actually works, and watches for side effects, in a larger group.
- Participants
-
About 165 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2023
- Expected to finish
-
Oct 2028
An estimate. End dates often move.
- Lead sponsor
-
A government research agency
The lead sponsor is the US National Institutes of Health.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient must have enrolled onto EAY191 and must have been given a treatment assignment to ComboMATCH to EAY191-N4 based on the presence of an actionable mutation as defined in EAY191 * Patients must be enrolled on the ComboMATCH Master Registration Trial EAY191 * Patients must have RAS pathway mutations as determined by the ComboMATCH screening assessment * Cohort 1: Patients with histologically confirmed RAS pathway mutant ovarian, primary peritoneal, or fallopian tube ("ovarian") cancer (activating mutations in KRAS, NRAS, HRAS, BRAF, MEK1, MEK2, or inactivating mutations in NF1) * Cohort 2: Patients with histologically confirmed RAS pathway mutant endometrial cancer (activating mutations in KRAS, NRAS, HRAS, BRAF, MEK1, MEK2, or inactivating mutations in NF1) * Patients must have disease that can be safely biopsied and agree to a pre-treatment biopsy or, if disease cannot be safely biopsied, have archival tissue available from within 12 months prior to the date of registration on the ComboMATCH Registration Trial (EAY191) * Patients must have progressed after first-line treatment for recurrent or persistent disease * Patients with ovarian cancer should not be eligible for further platinum-based therapy * Patients with endometrial cancer must have received or been offered an immune oncology agent (alone or in combination with lenvatinib) unless there are existing contraindications for immune oncology agents or lenvatinib * Patients may have received unlimited prior therapy * Patients must have measurable and biopsiable disease. Measurable disease is defined by RECIST 1.1 as at least one lesion that can be accurately measured in at least one dimension (longest diameter to be recorded). Each lesion must be \> 10 mm when measured by CT, magnetic resonance imaging (MRI) or caliper measurement by clinical exam; or \> 20 mm when measured by chest x-ray. Lymph nodes must be \> 15 mm in short axis when measured by CT or MRI * Patients must have at least one "target lesion" separate from the lesion to be biopsied to be used to assess response on this protocol as defined by RECIST version 1.1. Tumors within a previously irradiated field will be designated as "non-target" lesions unless progression is documented or a biopsy is obtained to confirm persistence at least 90 days following completion of radiation therapy * Prior therapy must have been completed at least four weeks prior to registration * Age \>= 18 * Eastern Cooperative Oncology Group (ECOG) Performance Status of 0, 1 or 2 * Hemoglobin (Hgb) \>= 9.5 g/dL with no blood transfusion in the past 28 days (within 14 days prior to registration) * Platelets \>= 100,000/mcl (within 14 days prior to registration) * Absolute neutrophil count (ANC) \>= 1,500/mcl (within 14 days prior to registration) * Patients must have creatinine clearance estimated of \>= 50 mL/min using the Cockcroft-Gault equation or based on a 24 hour urine test (within 14 days prior to registration) * Total bilirubin level =\< 1.5 x institutional upper limit of normal (ULN) or =\< 3 x ULN in the presence of documented Gilbert's syndrome (unconjugated hyperbilirubinemia) (within 14 days prior to registration) * Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =\< 3 x ULN (within 14 days prior to registration) * Patients must be able to swallow and retain oral medications and be without gastrointestinal illnesses that would preclude absorption of selumetinib or olaparib * Patients with known history or current symptoms of cardiac disease, or history of treatment with cardiotoxic agents, should have a clinical risk assessment of cardiac function using the New York Heart Association Functional Classification. To be eligible for this trial, patients should be class 2B or better * Women of childbearing potential (WOCBP) must agree to use two forms of birth control (hormonal or barrier method of birth control; abstinence) during the study and for 6 months after completing treatment * Non-sterilized male partners of WOCBP (including males sterilized by a method other than bilateral orchidectomy e.g., vasectomy) who intend to be sexually active with a female partner must be using an acceptable method of contraception such as male condom plus spermicide (condom alone in countries where spermicides are not approved) from the time of screening throughout the total duration of the study and the drug washout period (at least 6 months after the last dose of study intervention) to prevent pregnancy in a partner. Periodic abstinence, the rhythm method, and the withdrawal method are not acceptable methods of contraception. Vasectomized (i.e., sterile) males are considered fertile and should still use a male condom plus spermicide as indicated above during the clinical study * Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial * Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months of registration are eligible for this trial * Patients with evidence of chronic hepatitis B virus (HBV) infection must have an undetectable HBV viral load on suppressive therapy, if indicated * Patients with a history of hepatitis C virus (HCV) infection must have been treated and cured. For patients with HCV infection who are currently on treatment, they are eligible if they have an undetectable HCV viral load * Patients with new or progressive brain metastases (active brain metastases) or leptomeningeal disease are eligible if the treating physician determines that immediate central nervous system (CNS) specific treatment is not required and is unlikely to be required during the first cycle of therapy * Patients with treated brain metastases are eligible if follow-up brain imaging after CNS-directed therapy shows no evidence of progression * Extra caution should be taken with olaparib, as it crosses the blood brain barrier and can cause edema in brain metastases * The patient or a legally authorized representative must provide study-specific informed consent prior to study entry and, for patients treated in the United States (U.S.), authorization permitting release of personal health information Exclusion Criteria: * Patients who have received any MEK inhibitors * Patients who have progressed while receiving a PARP inhibitor * Patients who have received chemotherapy or radiotherapy within 4 weeks (6 weeks for nitrosoureas or mitomycin C) prior to registration * Patients who have not recovered from adverse events due to prior anti-cancer therapy (i.e., have residual toxicities \> grade 1) with the exception of alopecia * Patients with uncontrolled intercurrent illness * Patients with \>= grade 2 neuropathy within 14 days of registration * Patients with severe (Child-Pugh C) liver dysfunction * Patients with a history of allergic reactions attributed to compounds of similar chemical or biologic composition to olaparib and selumetinib or any excipients thereof * Concomitant use of known strong (e.g., phenobarbital, enzalutamide, phenytoin, rifampicin, rifabutin, rifapentine, carbamazepine, nevirapine and St John's Wort) or moderate CYP3A inducers (e.g., bosentan, efavirenz, modafinil). The required washout period prior to starting olaparib is 5 weeks for enzalutamide or phenobarbital and 3 weeks for other agents * Supplementation with vitamin E greater than 100% of the daily recommended dose. Any multivitamin containing vitamin E must be stopped prior to study enrollment even if less than 100% of the daily recommended dosing for vitamin E * Vitamin E must not be taken in the 7 days prior to initiation of treatment with selumetinib * Concomitant use of known strong CYP3A inhibitors (e.g., itraconazole, telithromycin, clarithromycin, protease inhibitors boosted with ritonavir or cobicistat, indinavir, saquinavir, nelfinavir, boceprevir, telaprevir) or known moderate CYP3A inhibitors (e.g. ciprofloxacin, erythromycin, diltiazem, Fluconazole, verapamil). The required washout period prior to starting olaparib is at least 14 days or 5 half-lives (whichever is longer) before the first dose of study medication * Concomitant use of strong CYP2C19 inhibitors (e.g., ticlopidine) or moderate CYP2C19 inhibitors (e.g., omeprazole). The required washout period prior to starting selumetinib is at least 14 days or 5 half-lives (whichever is longer) before the first dose of study medication * Have received or are receiving an investigational medicinal product (IMP) or other systemic anti-cancer treatment (including chemotherapy, immunotherapy, targeted therapy, biologic therapy, tumor embolization, or monoclonal antibodies) within 4 weeks prior to registration, or within a period during which the IMP or systemic target treatment has not been cleared from the body (e.g., a period of 5 'half-lives'), whichever is longer * Known myelodysplastic syndrome/acute myeloid leukemia or with features suggestive of myelodysplastic syndrome (MDS)/acute myeloid leukemia (AML) * Patients who have had previous organ transplant, allogenic bone marrow transplant or double umbilical cord blood transplantation * Patients who have had whole blood transfusion within 28 days prior to registration * Patients with ophthalmological conditions as follows: * Current or past history of retinal pigment epithelial detachment/central serous retinopathy or retinal vein occlusion. * Intraocular pressure \> 21 mmHg (or ULN adjusted by age) or uncontrolled glaucoma (irrespective of intraocular pressure \[IOP\]). Subjects with known glaucoma and increased IOP who do not have meaningful vision (light perception only or no light perception) and are not experiencing pain related to the glaucoma, may be eligible after discussion with the study chair * Patients with any other significant abnormality on ophthalmic examination should be discussed with the study chair for potential eligibility * Ophthalmological findings secondary to long-standing optic pathway glioma (such as visual loss, optic nerve pallor or strabismus) or longstanding orbito-temporal plexiform neurofibroma (PN) (such as visual loss, strabismus) will NOT be considered a significant abnormality for the purposes of the study * Patients with severe, active co-morbidity defined as any of the following: * History and/or confirmed pneumonitis * Uncontrolled hypertension (blood pressure \[BP\] \>= 150/90 mmHg despite medical therapy) * Acute coronary syndrome within 6 months prior to registration * Uncontrolled atrial fibrillation * Known family history of long QT syndrome * Women who are pregnant or unwilling to discontinue nursing
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Recurrent endometrial carcinoma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AMG Crystal Lake - Oncology
Crystal Lake, Illinois, 60014, United States
-
AMG Libertyville - Oncology
Libertyville, Illinois, 60048, United States
-
Abbott-Northwestern Hospital
Minneapolis, Minnesota, 55407, United States
-
Adena Regional Medical Center
Chillicothe, Ohio, 45601, United States
-
Advocate Christ Medical Center
Oak Lawn, Illinois, 60453-2699, United States
-
Advocate Good Samaritan Hospital
Downers Grove, Illinois, 60515, United States
-
Advocate Good Shepherd Hospital
Barrington, Illinois, 60010, United States
-
Advocate Illinois Masonic Medical Center
Chicago, Illinois, 60657, United States
-
Advocate Lutheran General Hospital
Park Ridge, Illinois, 60068, United States
-
Advocate Sherman Hospital
Elgin, Illinois, 60123, United States
-
Advocate South Suburban Hospital
Hazel Crest, Illinois, 60429, United States
-
Alaska Women's Cancer Care
Anchorage, Alaska, 99508, United States
-
Annie Penn Memorial Hospital
Reidsville, North Carolina, 27320, United States
-
Asplundh Cancer Pavilion
Willow Grove, Pennsylvania, 19090, United States
-
Atrium Medical Center-Middletown Regional Hospital
Franklin, Ohio, 45005-1066, United States
-
Aultman Health Foundation
Canton, Ohio, 44710, United States
-
Aurora Bay Area Medical Group-Marinette
Marinette, Wisconsin, 54143, United States
-
Aurora BayCare Medical Center
Green Bay, Wisconsin, 54311, United States
-
Aurora Cancer Care-Grafton
Grafton, Wisconsin, 53024, United States
-
Aurora Cancer Care-Kenosha South
Kenosha, Wisconsin, 53142, United States
-
Aurora Cancer Care-Milwaukee
Milwaukee, Wisconsin, 53209, United States
-
Aurora Cancer Care-Milwaukee West
Wauwatosa, Wisconsin, 53226, United States
-
Aurora Cancer Care-Racine
Racine, Wisconsin, 53406, United States
-
Aurora Cancer Care-Southern Lakes VLCC
Burlington, Wisconsin, 53105, United States
-
Aurora Health Care Germantown Health Center
Germantown, Wisconsin, 53022, United States
-
Aurora Medical Center in Summit
Summit, Wisconsin, 53066, United States
-
Aurora Saint Luke's Medical Center
Milwaukee, Wisconsin, 53215, United States
-
Aurora Saint Luke's South Shore
Cudahy, Wisconsin, 53110, United States
-
Aurora Sinai Medical Center
Milwaukee, Wisconsin, 53233, United States
-
Aurora West Allis Medical Center
West Allis, Wisconsin, 53227, United States
-
Baystate Medical Center
Springfield, Massachusetts, 01199, United States
-
Benefis Sletten Cancer Institute
Great Falls, Montana, 59405, United States
-
Billings Clinic Cancer Center
Billings, Montana, 59101, United States
-
Bozeman Health Deaconess Hospital
Bozeman, Montana, 59715, United States
-
Bryn Mawr Hospital
Bryn Mawr, Pennsylvania, 19010, United States
-
CTCA at Western Regional Medical Center
Goodyear, Arizona, 85338, United States
-
Cancer Care Center of O'Fallon
O'Fallon, Illinois, 62269, United States
-
Cancer Care Specialists of Illinois - Decatur
Decatur, Illinois, 62526, United States
-
Cancer Center of Western Wisconsin
New Richmond, Wisconsin, 54017, United States
-
Cancer Hematology Centers - Flint
Flint, Michigan, 48503, United States
-
Carilion Roanoke Memorial Hospital
Roanoke, Virginia, 24033, United States
-
Carle BroMenn Medical Center
Normal, Illinois, 61761, United States
-
Carle Cancer Center
Urbana, Illinois, 61801, United States
-
Carle Cancer Institute Normal
Normal, Illinois, 61761, United States
-
Carle Physician Group-Effingham
Effingham, Illinois, 62401, United States
-
Carle Physician Group-Mattoon/Charleston
Mattoon, Illinois, 61938, United States
-
Carle at The Riverfront
Danville, Illinois, 61832, United States
-
Case Western Reserve University
Cleveland, Ohio, 44106, United States
-
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
-
Centralia Oncology Clinic
Centralia, Illinois, 62801, United States
-
Centro Comprensivo de Cancer de UPR
San Juan, 00927, Puerto Rico
-
Chelsea Hospital
Chelsea, Michigan, 48118, United States
-
Community Hospital of Anaconda
Anaconda, Montana, 59711, United States
-
Community Medical Center
Missoula, Montana, 59804, United States
-
Condell Memorial Hospital
Libertyville, Illinois, 60048, United States
-
Cone Health Cancer Center
Greensboro, North Carolina, 27403, United States
-
Cone Health Cancer Center at Alamance Regional
Burlington, North Carolina, 27215, United States
-
Cone Health Cancer Center at Drawbridge Parkway
Greensboro, North Carolina, 27410, United States
-
Cone Health MedCenter Asheboro
Asheboro, North Carolina, 27205, United States
-
Corewell Health Beaumont Troy Hospital
Troy, Michigan, 48085, United States
-
Corewell Health Dearborn Hospital
Dearborn, Michigan, 48124, United States
-
Corewell Health Farmington Hills Hospital
Farmington Hills, Michigan, 48336, United States
-
Corewell Health William Beaumont University Hospital
Royal Oak, Michigan, 48073, United States
-
Crossroads Cancer Center
Effingham, Illinois, 62401, United States
-
Dayton Physician LLC - Englewood
Dayton, Ohio, 45415, United States
-
Decatur Memorial Hospital
Decatur, Illinois, 62526, United States
-
Dublin Methodist Hospital
Dublin, Ohio, 43016, United States
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
-
Duke Women's Cancer Care Raleigh
Raleigh, North Carolina, 27607, United States
-
Duluth Clinic Ashland
Ashland, Wisconsin, 54806, United States
-
Edwards Comprehensive Cancer Center
Huntington, West Virginia, 25701, United States
-
Essentia Health - Deer River Clinic
Deer River, Minnesota, 56636, United States
-
Essentia Health Cancer Center
Duluth, Minnesota, 55805, United States
-
Essentia Health Hibbing Clinic
Hibbing, Minnesota, 55746, United States
-
Essentia Health Sandstone
Sandstone, Minnesota, 55072, United States
-
Essentia Health Virginia Clinic
Virginia, Minnesota, 55792, United States
-
Fairfield Medical Center
Lancaster, Ohio, 43130, United States
-
Fairview Clinics and Surgery Center Maple Grove
Maple Grove, Minnesota, 55369, United States
-
Fairview Southdale Hospital
Edina, Minnesota, 55435, United States
-
Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111, United States
-
Genesee Hematology Oncology PC
Flint, Michigan, 48503, United States
-
Genesis Healthcare System Cancer Care Center
Zanesville, Ohio, 43701, United States
-
Genesys Hurley Cancer Institute
Flint, Michigan, 48503, United States
-
Good Samaritan Hospital - Cincinnati
Cincinnati, Ohio, 45220, United States
-
Gundersen Lutheran Medical Center
La Crosse, Wisconsin, 54601, United States
-
Harold Alfond Center for Cancer Care
Augusta, Maine, 04330, United States
-
Henrico Doctor's Hospital
Richmond, Virginia, 23229, United States
-
Henry Ford Saint John Hospital - Macomb Medical
Macomb, Michigan, 48044, United States
-
Hope Women's Cancer Centers-Asheville
Asheville, North Carolina, 28816, United States
-
Hurley Medical Center
Flint, Michigan, 48503, United States
-
Huron Gastroenterology PC
Ypsilanti, Michigan, 48106, United States
-
Illinois CancerCare - Washington
Washington, Illinois, 61571, United States
-
Illinois CancerCare-Bloomington
Bloomington, Illinois, 61704, United States
-
Illinois CancerCare-Canton
Canton, Illinois, 61520, United States
-
Illinois CancerCare-Carthage
Carthage, Illinois, 62321, United States
-
Illinois CancerCare-Dixon
Dixon, Illinois, 61021, United States
-
Illinois CancerCare-Eureka
Eureka, Illinois, 61530, United States
-
Illinois CancerCare-Galesburg
Galesburg, Illinois, 61401, United States
-
Illinois CancerCare-Kewanee Clinic
Kewanee, Illinois, 61443, United States
-
Illinois CancerCare-Macomb
Macomb, Illinois, 61455, United States
-
Illinois CancerCare-Ottawa Clinic
Ottawa, Illinois, 61350, United States
-
Illinois CancerCare-Pekin
Pekin, Illinois, 61554, United States
-
Illinois CancerCare-Peoria
Peoria, Illinois, 61615, United States
-
Illinois CancerCare-Peru
Peru, Illinois, 61354, United States
-
Illinois CancerCare-Princeton
Princeton, Illinois, 61356, United States
-
Jersey City Medical Center
Jersey City, New Jersey, 07302, United States
-
John H Stroger Jr Hospital of Cook County
Chicago, Illinois, 60612, United States
-
Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, 96826, United States
-
Kettering Medical Center
Kettering, Ohio, 45429, United States
-
Kingman Regional Medical Center
Kingman, Arizona, 86401, United States
-
Knox Community Hospital
Mount Vernon, Ohio, 43050, United States
-
Kootenai Clinic Cancer Services - Post Falls
Post Falls, Idaho, 83854, United States
-
Kootenai Clinic Cancer Services - Sandpoint
Sandpoint, Idaho, 83864, United States
-
Kootenai Health - Coeur d'Alene
Coeur d'Alene, Idaho, 83814, United States
-
Lafayette Family Cancer Center-EMMC
Brewer, Maine, 04412, United States
-
Lankenau Medical Center
Wynnewood, Pennsylvania, 19096, United States
-
Lehigh Valley Hospital - Muhlenberg
Bethlehem, Pennsylvania, 18017, United States
-
Lehigh Valley Hospital-Cedar Crest
Allentown, Pennsylvania, 18103, United States
-
Licking Memorial Hospital
Newark, Ohio, 43055, United States
-
Logan Health Medical Center
Kalispell, Montana, 59901, United States
-
Lyndon Baines Johnson General Hospital
Houston, Texas, 77026-1967, United States
-
MaineHealth Maine Medical Center- Scarborough
Scarborough, Maine, 04074, United States
-
Marietta Memorial Hospital
Marietta, Ohio, 45750, United States
-
Mayo Clinic in Florida
Jacksonville, Florida, 32224-9980, United States
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
-
Memorial Hospital
Marysville, Ohio, 43040, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Memorial Sloan Kettering Commack
Commack, New York, 11725, United States
-
Memorial Sloan Kettering Monmouth
Middletown, New Jersey, 07748, United States
-
Memorial Sloan Kettering Westchester
Harrison, New York, 10604, United States
-
Mercy Health - Perrysburg Hospital
Perrysburg, Ohio, 43551, United States
-
Mercy Health - Saint Anne Hospital
Toledo, Ohio, 43623, United States
-
Mercy Hospital
Coon Rapids, Minnesota, 55433, United States
-
Mercy Medical Center - Des Moines
Des Moines, Iowa, 50314, United States
-
Miami Valley Cancer Care and Infusion
Greenville, Ohio, 45331, United States
-
Miami Valley Hospital
Dayton, Ohio, 45409, United States
-
Miami Valley Hospital North
Dayton, Ohio, 45415, United States
-
Miami Valley Hospital South
Centerville, Ohio, 45459, United States
-
Mission Hospital
Asheville, North Carolina, 28801, United States
-
Missouri Baptist Medical Center
St Louis, Missouri, 63131, United States
-
Missouri Baptist Sullivan Hospital
Sullivan, Missouri, 63080, United States
-
Monmouth Medical Center
Long Branch, New Jersey, 07740, United States
-
Monmouth Medical Center Southern Campus
Lakewood, New Jersey, 08701, United States
-
Mount Carmel East Hospital
Columbus, Ohio, 43213, United States
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
-
North Star Lodge Cancer Center at Yakima Valley Memorial Hospital
Yakima, Washington, 98902, United States
-
NorthShore University HealthSystem-Evanston Hospital
Evanston, Illinois, 60201, United States
-
NorthShore University HealthSystem-Glenbrook Hospital
Glenview, Illinois, 60026, United States
-
NorthShore University HealthSystem-Highland Park Hospital
Highland Park, Illinois, 60035, United States
-
Ochsner Baptist Medical Center
New Orleans, Louisiana, 70115, United States
-
Ochsner Medical Center Jefferson
New Orleans, Louisiana, 70121, United States
-
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
-
OhioHealth Mansfield Hospital
Mansfield, Ohio, 44903, United States
-
OhioHealth Pickerington Methodist Hospital
Pickerington, Ohio, 43147, United States
-
OhioHealth Westerville Medical Campus/Westerville Cancer Center
Westerville, Ohio, 43082, United States
-
OptumCare Cancer Care at Charleston
Las Vegas, Nevada, 89102, United States
-
OptumCare Cancer Care at Fort Apache
Las Vegas, Nevada, 89183, United States
-
Oregon Health and Science University
Portland, Oregon, 97239, United States
-
PCR Oncology
Arroyo Grande, California, 93420, United States
-
PROncology
San Juan, 00927, Puerto Rico
-
Paoli Memorial Hospital
Paoli, Pennsylvania, 19301, United States
-
Park Nicollet Clinic - Saint Louis Park
Saint Louis Park, Minnesota, 55416, United States
-
Parkland Health Center - Farmington
Farmington, Missouri, 63640, United States
-
Pennsylvania Hospital
Philadelphia, Pennsylvania, 19107, United States
-
Pocono Medical Center
East Stroudsburg, Pennsylvania, 18301, United States
-
Presbyterian Intercommunity Hospital
Whittier, California, 90602, United States
-
Providence Newberg Medical Center
Newberg, Oregon, 97132, United States
-
Providence Portland Medical Center
Portland, Oregon, 97213, United States
-
Providence Regional Cancer System-Lacey
Lacey, Washington, 98503, United States
-
Providence Saint Mary Regional Cancer Center
Walla Walla, Washington, 99362, United States
-
Providence Saint Vincent Medical Center
Portland, Oregon, 97225, United States
-
Providence Willamette Falls Medical Center
Oregon City, Oregon, 97045, United States
-
Puerto Rico Hematology Oncology Group
Bayamón, 00961, Puerto Rico
-
Queen's Cancer Cenrer - POB I
Honolulu, Hawaii, 96813, United States
-
Queen's Cancer Center - Kuakini
Honolulu, Hawaii, 96817, United States
-
Queen's Medical Center
Honolulu, Hawaii, 96813, United States
-
Rapid City Regional Hospital
Rapid City, South Dakota, 57701, United States
-
Regions Hospital
Saint Paul, Minnesota, 55101, United States
-
Riddle Memorial Hospital
Media, Pennsylvania, 19063, United States
-
Riverside Methodist Hospital
Columbus, Ohio, 43214, United States
-
Roswell Park Cancer Institute
Buffalo, New York, 14263, United States
-
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, 08903, United States
-
Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, 83706, United States
-
Saint Alphonsus Cancer Care Center-Caldwell
Caldwell, Idaho, 83605, United States
-
Saint Alphonsus Cancer Care Center-Nampa
Nampa, Idaho, 83687, United States
-
Saint Alphonsus Cancer Care Center-Ontario
Ontario, Oregon, 97914, United States
-
Saint Ann's Hospital
Westerville, Ohio, 43081, United States
-
Saint Francis Medical Center
Cape Girardeau, Missouri, 63703, United States
-
Saint Joseph Hospital - Orange
Orange, California, 92868, United States
-
Saint Luke's Cancer Institute - Boise
Boise, Idaho, 83712, United States
-
Saint Luke's Cancer Institute - Fruitland
Fruitland, Idaho, 83619, United States
-
Saint Luke's Cancer Institute - Meridian
Meridian, Idaho, 83642, United States
-
Saint Luke's Cancer Institute - Nampa
Nampa, Idaho, 83687, United States
-
Saint Luke's Cancer Institute - Twin Falls
Twin Falls, Idaho, 83301, United States
-
Saint Vincent Hospital Cancer Center Green Bay
Green Bay, Wisconsin, 54301, United States
-
Saint Vincent Hospital Cancer Center at Oconto Falls
Oconto Falls, Wisconsin, 54154, United States
-
Saint Vincent Hospital Cancer Center at Saint Mary's
Green Bay, Wisconsin, 54303, United States
-
Saint Vincent Hospital Cancer Center at Sheboygan
Sheboygan, Wisconsin, 53081, United States
-
Saint Vincent Hospital Cancer Center at Sturgeon Bay
Sturgeon Bay, Wisconsin, 54235-1495, United States
-
Sainte Genevieve County Memorial Hospital
Sainte Genevieve, Missouri, 63670, United States
-
Sanford Bismarck Medical Center
Bismarck, North Dakota, 58501, United States
-
Sanford Broadway Medical Center
Fargo, North Dakota, 58122, United States
-
Sanford Cancer Center Oncology Clinic
Sioux Falls, South Dakota, 57104, United States
-
Sanford Roger Maris Cancer Center
Fargo, North Dakota, 58122, United States
-
Sanford USD Medical Center - Sioux Falls
Sioux Falls, South Dakota, 57117-5134, United States
-
Sidney Kimmel Cancer Center Washington Township
Sewell, New Jersey, 08080, United States
-
Southern Illinois University School of Medicine
Springfield, Illinois, 62702, United States
-
Southern Ohio Medical Center
Portsmouth, Ohio, 45662, United States
-
Springfield Clinic
Springfield, Illinois, 62702, United States
-
Springfield Memorial Hospital
Springfield, Illinois, 62781, United States
-
Springfield Regional Cancer Center
Springfield, Ohio, 45504, United States
-
Springfield Regional Medical Center
Springfield, Ohio, 45504, United States
-
Stanford Cancer Institute Palo Alto
Palo Alto, California, 94304, United States
-
State University of New York Upstate Medical University
Syracuse, New York, 13210, United States
-
Strecker Cancer Center-Belpre
Belpre, Ohio, 45714, United States
-
Swedish Cancer Institute-Edmonds
Edmonds, Washington, 98026, United States
-
Swedish Cancer Institute-Issaquah
Issaquah, Washington, 98029, United States
-
Swedish Medical Center-First Hill
Seattle, Washington, 98122, United States
-
The Mark H Zangmeister Center
Columbus, Ohio, 43219, United States
-
The Queen's Medical Center - West Oahu
‘Ewa Beach, Hawaii, 96706, United States
-
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, 19107, United States
-
Trinity Health IHA Medical Group Hematology Oncology - Brighton
Brighton, Michigan, 48114, United States
-
Trinity Health IHA Medical Group Hematology Oncology - Canton
Canton, Michigan, 48188, United States
-
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
Chelsea, Michigan, 48118, United States
-
Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
Ypsilanti, Michigan, 48197, United States
-
Trinity Health Medical Center - Brighton
Brighton, Michigan, 48114, United States
-
Trinity Health Medical Center - Canton
Canton, Michigan, 48188, United States
-
Trinity Health Saint Joseph Mercy Hospital Ann Arbor
Ann Arbor, Michigan, 48106, United States
-
Trinity Health Saint Joseph Mercy Oakland Hospital
Pontiac, Michigan, 48341, United States
-
Trinity Health Saint Mary Mercy Livonia Hospital
Livonia, Michigan, 48154, United States
-
Tufts Medical Center
Boston, Massachusetts, 02111, United States
-
Tufts Medical Center Cancer Center Stoneham
Stoneham, Massachusetts, 02180, United States
-
UC Comprehensive Cancer Center at Silver Cross
New Lenox, Illinois, 60451, United States
-
UChicago Medicine Northwest Indiana
Crown Point, Indiana, 46307, United States
-
UH Seidman Cancer Center at Lake Health Mentor Campus
Mentor, Ohio, 44060, United States
-
UH Seidman Cancer Center at Saint John Medical Center
Westlake, Ohio, 44145, United States
-
UH Seidman Cancer Center at UH Avon Health Center
Avon, Ohio, 44011, United States
-
UHHS-Chagrin Highlands Medical Center
Beachwood, Ohio, 44122, United States
-
UI Health Care Mission Cancer and Blood - Ankeny Clinic
Ankeny, Iowa, 50023, United States
-
UI Health Care Mission Cancer and Blood - Des Moines Clinic
Des Moines, Iowa, 50309, United States
-
UI Health Care Mission Cancer and Blood - Laurel Clinic
Des Moines, Iowa, 50314, United States
-
UI Health Care Mission Cancer and Blood - Waukee Clinic
Waukee, Iowa, 50263, United States
-
UI Health Care Mission Cancer and Blood - West Des Moines Clinic
Clive, Iowa, 50325, United States
-
UM Sylvester Comprehensive Cancer Center at Aventura
Aventura, Florida, 33180, United States
-
UM Sylvester Comprehensive Cancer Center at Coral Gables
Coral Gables, Florida, 33146, United States
-
UM Sylvester Comprehensive Cancer Center at Deerfield Beach
Deerfield Beach, Florida, 33442, United States
-
UM Sylvester Comprehensive Cancer Center at Kendall
Miami, Florida, 33176, United States
-
UM Sylvester Comprehensive Cancer Center at Plantation
Plantation, Florida, 33324, United States
-
UPMC Altoona
Altoona, Pennsylvania, 16601, United States
-
UPMC Cancer Centers - Arnold Palmer Pavilion
Greensburg, Pennsylvania, 15601, United States
-
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania, 15232, United States
-
UPMC Hillman Cancer Center - Monroeville
Monroeville, Pennsylvania, 15146, United States
-
UPMC Hillman Cancer Center Erie
Erie, Pennsylvania, 16505, United States
-
UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion
Mechanicsburg, Pennsylvania, 17050, United States
-
UPMC Western Maryland
Cumberland, Maryland, 21502, United States
-
UPMC-Magee Womens Hospital
Pittsburgh, Pennsylvania, 15213, United States
-
UPMC-Passavant Hospital
Pittsburgh, Pennsylvania, 15237, United States
-
UT MD Anderson - League City
League City, Texas, 77573, United States
-
UT MD Anderson - Sugar Land
Sugar Land, Texas, 77478, United States
-
UT MD Anderson - The Woodlands
Conroe, Texas, 77384, United States
-
UT MD Anderson - West Houston
Houston, Texas, 77079, United States
-
UT MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
UT Southwestern/Simmons Cancer Center-Dallas
Dallas, Texas, 75390, United States
-
United Hospital
Saint Paul, Minnesota, 55102, United States
-
University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, 35233, United States
-
University of Chicago Comprehensive Cancer Center
Chicago, Illinois, 60637, United States
-
University of Chicago Medicine-Orland Park
Orland Park, Illinois, 60462, United States
-
University of Hawaii Cancer Center
Honolulu, Hawaii, 96813, United States
-
University of Illinois
Chicago, Illinois, 60612, United States
-
University of Kentucky/Markey Cancer Center
Lexington, Kentucky, 40536, United States
-
University of Maryland/Greenebaum Cancer Center
Baltimore, Maryland, 21201, United States
-
University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, 33136, United States
-
University of Miami Sylvester Comprehensive Cancer Center at Sole Mia
North Miami, Florida, 33181, United States
-
University of Michigan - Brighton Center for Specialty Care
Brighton, Michigan, 48116, United States
-
University of Michigan Health - Sparrow Lansing
Lansing, Michigan, 48912, United States
-
University of Michigan Rogel Cancer Center
Ann Arbor, Michigan, 48109, United States
-
University of New Mexico Cancer Center
Albuquerque, New Mexico, 87106, United States
-
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, 73104, United States
-
University of South Alabama Mitchell Cancer Institute
Mobile, Alabama, 36688, United States
-
University of Virginia Cancer Center
Charlottesville, Virginia, 22908, United States
-
University of Wisconsin Carbone Cancer Center - Eastpark Medical Center
Madison, Wisconsin, 53718, United States
-
University of Wisconsin Carbone Cancer Center - University Hospital
Madison, Wisconsin, 53792, United States
-
Upper Valley Medical Center
Troy, Ohio, 45373, United States
-
VCU Community Memorial Health Center
South Hill, Virginia, 23970, United States
-
VCU Massey Cancer Center at Stony Point
Richmond, Virginia, 23235, United States
-
VCU Massey Comprehensive Cancer Center
Richmond, Virginia, 23298, United States
-
Valley Medical Center
Renton, Washington, 98055, United States
-
Vince Lombardi Cancer Clinic - Oshkosh
Oshkosh, Wisconsin, 54904, United States
-
Vince Lombardi Cancer Clinic-Sheboygan
Sheboygan, Wisconsin, 53081, United States
-
Vince Lombardi Cancer Clinic-Two Rivers
Two Rivers, Wisconsin, 54241, United States
-
Virginia Cancer Institute
Richmond, Virginia, 23229, United States
-
Walter Reed National Military Medical Center
Bethesda, Maryland, 20889-5600, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
-
West Virginia University Healthcare
Morgantown, West Virginia, 26506, United States
-
Women and Infants Hospital
Providence, Rhode Island, 02905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Drug combo outsmart resistant breast and ovarian cancers?
- Targeted pill aims to halt recurrent ovarian and endometrial cancers
- Hormone blocker plus targeted drug shows promise against tough uterine cancer
- New hope for Platinum-Resistant ovarian cancer: ONC201 and paclitaxel combo trial launches
- Cancer drug combo tested for rare gene mutation – but trial stopped early
- New targeted therapy shows promise for Tough-to-Treat ovarian cancer